These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 5150985

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Pulmonary hemorrhage and hemoptysis in patients admitted to a tuberculosis hospital].
    Tabidze Sha, Diasamidze MO, Mamulashvili ShA.
    Klin Med (Mosk); 1981 Dec; 59(12):22-6. PubMed ID: 7339183
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fibrinolysis and its control.
    Andersson L.
    S Afr Med J; 1972 Feb 19; 46(8):182-5. PubMed ID: 4260535
    [No Abstract] [Full Text] [Related]

  • 29. [Emergence of pulmonary hemorrhage and hemoptysis depending on the changes of certain synoptic and heliogeophysical factors].
    Navrotskiĭ VV, Azhitskiĭ IuA, Latyshev GD, Belov VP, Kvitchenko IV.
    Probl Tuberk; 1974 Feb 19; 52(6):52-3. PubMed ID: 4848643
    [No Abstract] [Full Text] [Related]

  • 30. [Research on the pathogenetic mechanisms of hemorrhages due to induced venous stasis. II. Role of fibrinolysis in the pathogenesis of the hemorrhagic phenomenon due to stasis].
    Neri Serneri GG, Rossi Ferrini PL, Franchi F, Paoletti P.
    Haematologica; 1965 Feb 19; 50(4):251-66. PubMed ID: 4953556
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical biochemical justification for the use of fibrinolysis inhibitors in the therapy of hemorrhages in ENT diseases].
    Veremeenko KN, Gerasimenko NG, Pogorelova LM.
    Zh Ushn Nos Gorl Bolezn; 1972 Feb 19; (3):56-61. PubMed ID: 4680879
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Blood coagulability in pulmonary hemorrhage in patients with tuberculosis].
    Shemetov AV.
    Probl Tuberk; 1968 Feb 19; 46(10):54-6. PubMed ID: 5711695
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical analysis of the causes of pulmonary hemorrhage].
    Adamczyk M, Winnicka-Wrona T, Durda M.
    Pol Tyg Lek; 1980 Dec 29; 35(52):2055-6. PubMed ID: 7027207
    [No Abstract] [Full Text] [Related]

  • 40. [Fibrinolytic activity of serum, urine and sputum in patients with bronchial asthma and in healthy subjects].
    Chachaj W, Semplawska-Maj B, Falowska-Adamczyk W, Wrzyszcz M.
    Pol Tyg Lek; 1971 Sep 13; 26(37):1422-4. PubMed ID: 5113277
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.